Prestige Consumer Healthcare Inc.
PBH· NYSE
Quarterly figures for Prestige Consumer Healthcare Inc., with source filings when available.
58 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
Prestige Consumer Healthcare Inc. has filed its 10-Q within 36 to 39 days of period end across its last 8 quarters. The 10-K runs 35 to 45 days.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2027 | |||||||||
| Q1 2027 | Jun 30, 2026 | Aug 6, 2026 · pre-market | Aug 6, 2026 | 37 d | 10-Q | $265.71M | +6.5% | $0.61 | |
| Q4 2026derived | Mar 31, 2026 | May 13, 2026 · after-hours | May 14, 2026 | 44 d | 10-K | $281.62M | −5.0% | — |
|---|
| Q3 2026 | Dec 31, 2025 | Feb 5, 2026 · pre-market | Feb 5, 2026 | 36 d | 10-Q | $283.44M | −2.4% | $0.97 |
|---|
| Q2 2026 | Sep 30, 2025 | Nov 6, 2025 · pre-market | Nov 6, 2025 | 37 d | 10-Q | $274.11M | −3.4% | $0.86 |
|---|
| Q1 2026 | Jun 30, 2025 | Aug 7, 2025 · pre-market | Aug 7, 2025 | 38 d | 10-Q | $249.53M | −6.6% | $0.95 |
|---|
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Mar 31, 2025 | May 8, 2025 · pre-market | May 9, 2025 | 39 d | 10-K | $296.52M | +7.0% | — | |
| Q3 2025 | Dec 31, 2024 | Feb 6, 2025 · pre-market | Feb 6, 2025 | 37 d | 10-Q | $290.32M | +2.7% | $1.22 | |
| Q2 2025 | Sep 30, 2024 | Nov 7, 2024 · pre-market | Nov 7, 2024 | 38 d | 10-Q | $283.79M | −0.9% | $1.09 | |
| Q1 2025 | Jun 30, 2024 | Aug 8, 2024 · pre-market | Aug 8, 2024 | 39 d | 10-Q | $267.14M | −4.4% | $0.98 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Mar 31, 2024 | May 14, 2024 · after-hours | May 15, 2024 | 45 d | 10-K | $276.99M | −3.1% | — | |
| Q3 2024 | Dec 31, 2023 | Feb 8, 2024 · pre-market | Feb 8, 2024 | 39 d | 10-Q | $282.74M | +2.6% | $1.06 | |
| Q2 2024 | Sep 30, 2023 | Nov 2, 2023 · pre-market | Nov 2, 2023 | 33 d | 10-Q | $286.32M | −1.0% | $1.07 | |
| Q1 2024 | Jun 30, 2023 | Aug 3, 2023 · pre-market | Aug 3, 2023 | 34 d | 10-Q | $279.31M | +0.8% | $1.06 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Mar 31, 2023 | May 4, 2023 · pre-market | May 5, 2023 | 35 d | 10-K | $285.87M | +7.1% | — | |
| Q3 2023 | Dec 31, 2022 | Feb 2, 2023 · pre-market | Feb 2, 2023 | 33 d | 10-Q | $275.52M | +0.4% | $1.04 | |
| Q2 2023 | Sep 30, 2022 | Nov 3, 2022 · pre-market | Nov 3, 2022 | 34 d | 10-Q | $289.27M | +4.7% | $1.02 | |
| Q1 2023 | Jun 30, 2022 | Aug 4, 2022 · pre-market | Aug 4, 2022 | 35 d | 10-Q | $277.06M | +2.9% | $1.09 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Mar 31, 2022 | May 5, 2022 · after-hours | May 6, 2022 | 36 d | 10-K | $266.94M | +12.3% | — | |
| Q3 2022 | Dec 31, 2021 | Feb 3, 2022 · pre-market | Feb 3, 2022 | 34 d | 10-Q | $274.47M | +14.9% | $0.99 | |
| Q2 2022 | Sep 30, 2021 | — | Nov 4, 2021 | 35 d | 10-Q | $276.23M | +16.3% | $0.89 | |
| Q1 2022 | Jun 30, 2021 | — | Aug 5, 2021 | 36 d | 10-Q | $269.18M | +17.3% | $1.14 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Mar 31, 2021 | — | May 7, 2021 | 37 d | 10-K | $237.76M | −5.4% | — | |
| Q3 2021 | Dec 31, 2020 | — | Feb 4, 2021 | 35 d | 10-Q | $238.79M | −1.1% | $0.81 | |
| Q2 2021 | Sep 30, 2020 | — | Nov 5, 2020 | 36 d | 10-Q | $237.42M | −0.3% | $0.88 | |
| Q1 2021 | Jun 30, 2020 | — | Aug 6, 2020 | 37 d | 10-Q | $229.39M | −1.2% | $0.86 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Mar 31, 2020 | — | May 8, 2020 | 38 d | 10-K | $251.24M | +4.2% | $0.73 | |
| Q3 2020 | Dec 31, 2019 | — | Feb 6, 2020 | 37 d | 10-Q | $241.55M | +0.1% | $0.75 | |
| Q2 2020 | Sep 30, 2019 | — | Oct 31, 2019 | 31 d | 10-Q | $238.07M | −0.5% | $0.65 | |
| Q1 2020 | Jun 30, 2019 | — | Aug 1, 2019 | 32 d | 10-Q | $232.15M | −8.6% | $0.65 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Mar 31, 2019 | — | May 13, 2019 | 43 d | 10-K | $241.03M | −5.8% | -$2.68 | |
| Q3 2019 | Dec 31, 2018 | — | Feb 7, 2019 | 38 d | 10-Q | $241.41M | −10.8% | $0.73 | |
| Q2 2019 | Sep 30, 2018 | — | Nov 1, 2018 | 32 d | 10-Q | $239.36M | −7.2% | $0.59 | |
| Q1 2019 | Jun 30, 2018 | — | Aug 2, 2018 | 33 d | 10-Q | $253.98M | −1.0% | $0.65 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Mar 31, 2018 | — | May 10, 2018 | 40 d | 10-K | $255.97M | +6.4% | -$0.75 | |
| Q3 2018 | Dec 31, 2017 | — | Feb 1, 2018 | 32 d | 10-Q | $270.62M | +24.8% | $5.88 | |
| Q2 2018 | Sep 30, 2017 | — | Nov 2, 2017 | 33 d | 10-Q | $258.03M | +20.0% | $0.57 | |
| Q1 2018 | Jun 30, 2017 | — | Aug 3, 2017 | 34 d | 10-Q | $256.57M | +22.4% | $0.63 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Mar 31, 2017 | — | May 17, 2017 | 47 d | 10-K | $240.67M | +15.8% | $0.21 | |
| Q3 2017 | Dec 31, 2016 | — | Feb 2, 2017 | 33 d | 10-Q | $216.76M | +8.3% | $0.59 | |
| Q2 2017 | Sep 30, 2016 | — | Nov 3, 2016 | 34 d | 10-Q | $215.05M | +4.4% | $0.60 | |
| Q1 2017 | Jun 30, 2016 | — | Aug 4, 2016 | 35 d | 10-Q | $209.58M | +9.1% | -$0.10 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Mar 31, 2016 | — | May 17, 2016 | 47 d | 10-K | $207.86M | +9.4% | $0.26 | |
| Q3 2016 | Dec 31, 2015 | — | Feb 4, 2016 | 35 d | 10-Q | $200.20M | +1.3% | $0.53 | |
| Q2 2016 | Sep 30, 2015 | — | Nov 5, 2015 | 36 d | 10-Q | $206.07M | +13.7% | $0.60 | |
| Q1 2016 | Jun 30, 2015 | — | Aug 6, 2015 | 37 d | 10-Q | $192.13M | +31.9% | $0.49 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Mar 31, 2015 | — | May 14, 2015 | 44 d | 10-K | $190.05M | — | $0.45 | |
| Q3 2015 | Dec 31, 2014 | — | Feb 5, 2015 | 36 d | 10-Q | $197.61M | — | $0.40 | |
| Q2 2015 | Sep 30, 2014 | — | Nov 6, 2014 | 37 d | 10-Q | $181.27M | — | $0.31 | |
| Q1 2015 | Jun 30, 2014 | — | Aug 7, 2014 | 38 d | 10-Q | $145.70M | — | $0.32 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q1 2012 | Jun 30, 2012 | — | Aug 9, 2012 | 40 d | 10-Q | $147.00M | +54.3% | $0.29 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011 | Mar 31, 2012 | — | May 18, 2012 | 48 d | 10-K | $134.00M | +39.1% | $0.00 | |
| Q3 2011 | Dec 31, 2011 | — | Feb 9, 2012 | 40 d | 10-Q | $106.25M | +17.3% | $0.19 | |
| Q2 2011 | Sep 30, 2011 | — | Nov 9, 2011 | 40 d | 10-Q | $105.54M | +34.8% | $0.26 | |
| Q1 2011 | Jun 30, 2011 | — | Aug 5, 2011 | 36 d | 10-Q | $95.30M | +33.8% | $0.29 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Mar 31, 2011 | — | May 13, 2011 | 43 d | 10-K | $96.36M | — | — | |
| Q3 2010 | Dec 31, 2010 | — | Feb 9, 2011 | 40 d | 10-Q | $90.61M | — | $0.04 | |
| Q2 2010 | Sep 30, 2010 | — | Nov 5, 2010 | 36 d | 10-Q | $78.30M | — | $0.22 | |
| Q1 2010 | Jun 30, 2010 | — | Aug 6, 2010 | 37 d | 10-Q | $71.24M | — | $0.19 | |